• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anaptysbio Inc (NQ: ANAB )

    33.98 -1.05 (-3.00%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 209,080
    Open 35.35
    Bid (Size) 31.34 (1)
    Ask (Size) 35.96 (2)
    Prev. Close 35.03
    Today's Range 33.27 - 35.56
    52wk Range 13.36 - 41.31
    Shares Outstanding 27,433,359
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    What Analysts Are Saying About AnaptysBio Stock
    Via Benzinga

    Performance

    YTD
    +56.59%
    +56.59%
    1 Month
    -8.48%
    -8.48%
    3 Month
    +37.29%
    +37.29%
    6 Month
    +61.20%
    +61.20%
    1 Year
    +72.14%
    +72.14%

    More News

    Read More
    Anaptys Announces Participation in September Investor Conferences
    From AnaptysBio, Inc.
    Via GlobeNewswire
    Why AnaptysBio Was Such a Healthy Stock This Week
    Via The Motley Fool
    Insiders Buying Yum China And 2 Other Stocks
    Via Benzinga
    4 Analysts Assess AnaptysBio: What You Need To Know
    Via Benzinga
    The Analyst Landscape: 7 Takes On AnaptysBio
    Via Benzinga
    Unveiling 4 Analyst Insights On AnaptysBio
    Via Benzinga
    UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    AnaptysBio Hits Five-Year High After Sanofi Takes A Stake In $100 Million Offering
    Via Investor's Business Daily
    S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
    Via Benzinga
    Topics ETFs Economy Stocks
    Exposures Interest Rates US Equities
    Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
    From AnaptysBio, Inc.
    Via GlobeNewswire
    ANAB Stock Earnings: AnaptysBio Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
    From AnaptysBio, Inc.
    Via GlobeNewswire
    AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
    Via Benzinga
    ANAB Stock Earnings: AnaptysBio Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
    From AnaptysBio, Inc.
    Via GlobeNewswire
    Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
    From AnaptysBio, Inc.
    Via GlobeNewswire
    Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties
    From AnaptysBio, Inc.
    Via GlobeNewswire
    BTIG Research Predicts Over 118% Rally for These 3 Stocks
    Via InvestorPlace
    Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
    Via The Motley Fool
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers
    Via Benzinga
    Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    From AnaptysBio, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.